---
title: "摩根士丹利重申对 Arcutis Biotherapeutics（ARQT）的买入评级"
description: "根据 TipRanks 的数据，Frommer 是一位 2 星分析师，平均回报率为 0.5%，成功率为 53.54%。Frommer 覆盖医疗保健行业，关注的股票包括 Galapagos、PTC Therapeutics 和 Zenas BioPharma, Inc.。目前，分析师对 Arcutis Biotherapeutics 的共识评级为强烈买入，平均目标价为 22.79 美元，比当前水平有"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261560617.md"
published_at: "2025-10-17T06:45:27.000Z"
---

# 摩根士丹利重申对 Arcutis Biotherapeutics（ARQT）的买入评级

> 根据 TipRanks 的数据，Frommer 是一位 2 星分析师，平均回报率为 0.5%，成功率为 53.54%。Frommer 覆盖医疗保健行业，关注的股票包括 Galapagos、PTC Therapeutics 和 Zenas BioPharma, Inc.。目前，分析师对 Arcutis Biotherapeutics 的共识评级为强烈买入，平均目标价为 22.79 美元，比当前水平有 8.99% 的上涨空间。在 10 月 6 日发布的一份报告中，Needham 也维持了该股票的买入评级，目标价为 22.00 美元

根据 TipRanks 的数据，Frommer 是一位 2 星分析师，平均回报率为 0.5%，成功率为 53.54%。Frommer 覆盖医疗保健行业，关注的股票包括 Galapagos、PTC Therapeutics 和 Zenas BioPharma, Inc..

目前，分析师对 Arcutis Biotherapeutics 的共识评级为强烈买入，平均目标价为 22.79 美元，比当前水平有 8.99% 的上涨空间。在 10 月 6 日发布的一份报告中，Needham 也维持了该股票的买入评级，目标价为 22.00 美元。

### Related Stocks

- [ARQT.US - Arcutis Biotherapeutics](https://longbridge.com/zh-CN/quote/ARQT.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Director Howard G. Welgus Reports Disposal of Arcutis Biotherapeutics Inc. Common Shares | Howard G. Welgus, Director of Arcutis Biotherapeutics Inc., reported the disposal of common shares. The full filing is a | [Link](https://longbridge.com/zh-CN/news/271706872.md) |
| Mizuho Securities Reaffirms Their Buy Rating on Arcutis Biotherapeutics (ARQT) | Mizuho Securities, through analyst Uy Ear, reaffirmed a Buy rating for Arcutis Biotherapeutics with a price target of $3 | [Link](https://longbridge.com/zh-CN/news/267587716.md) |
| Palvella Therapeutics (PVLA) Gets a Buy from Craig-Hallum | In a recent report, Craig-Hallum analyst Albert Lowe maintained a Buy rating on Palvella Therapeutics (PVLA) with a pric | [Link](https://longbridge.com/zh-CN/news/276240277.md) |
| Positive Report for LeonaBio (LONA) from Mizuho Securities | Mizuho Securities analyst Graig Suvannavejh upgraded LeonaBio (LONA) to a Buy with a price target of $10.00. Suvannavejh | [Link](https://longbridge.com/zh-CN/news/276278570.md) |
| Where Were The Job Opportunities In 2025? Where Will They Be In 2026? | In 2025, job growth was minimal, with only Education and Health Care (+697,000 jobs) and Leisure and Hospitality (+119,0 | [Link](https://longbridge.com/zh-CN/news/275986113.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。